Bryson Bryan D
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA.
mSphere. 2025 Sep 30;10(9):e0009125. doi: 10.1128/msphere.00091-25. Epub 2025 Sep 10.
Control of intracellular pathogens is a critical element of host defense. Defining the molecular mechanisms by which the host restricts or eliminates these pathogens may inform the development of novel immunotherapeutics and antimicrobial strategies, particularly in the face of rising antibiotic resistance. In parallel, understanding how pathogens subvert these immune responses may yield new approaches to disrupt virulence rather than viability. Yet, the precise mechanisms by which primates-and especially humans-achieve intracellular pathogen control remain poorly understood. Five years ago, I reflected on the complexity of interferon-induced control of in a murine infection model. In this review, I revisit those questions considering emerging evidence, highlighting how cross-species comparisons and context-specific immune programs are reshaping our understanding of host-pathogen interactions and the logic of antimicrobial defense.
控制细胞内病原体是宿主防御的关键要素。明确宿主限制或清除这些病原体的分子机制,可能为新型免疫疗法和抗菌策略的开发提供依据,尤其是在面对日益增加的抗生素耐药性时。与此同时,了解病原体如何颠覆这些免疫反应,可能会产生破坏毒力而非生存能力的新方法。然而,灵长类动物——尤其是人类——实现细胞内病原体控制的确切机制仍知之甚少。五年前,我思考了干扰素诱导的控制在小鼠感染模型中的复杂性。在这篇综述中,我结合新出现的证据重新审视这些问题,强调跨物种比较和特定背景的免疫程序如何重塑我们对宿主-病原体相互作用以及抗菌防御逻辑的理解。